Hims & Hers Health Inc (HIMS)

Jan 9, 2025, 8:39 AM EST - 8 days ago

Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns

Jan 7, 2025, 10:44 AM EST - 10 days ago

Hims & Hers donates $1 million to Trump's inauguration fund

Jan 2, 2025, 8:30 AM EST - 15 days ago

Hims & Hers: Ready For Liftoff In 2025

Dec 24, 2024, 8:00 AM EST - 24 days ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DOCS DXCM GDRX ME OSCR PGNY TDOC

Dec 23, 2024, 6:23 AM EST - 25 days ago

Hims & Hers: Still Trading At A Massive Discount

Dec 22, 2024, 3:01 AM EST - 26 days ago

Will the falling Hims & Hers stock price recover in 2025?

Dec 12, 2024, 9:00 AM EST - 5 weeks ago

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight

Dec 12, 2024, 4:51 AM EST - 5 weeks ago

Hims & Hers: Look At What Matters Most

Dec 10, 2024, 6:50 PM EST - 5 weeks ago

Options Action: Bearish bets on Hims

Dec 10, 2024, 3:23 PM EST - 5 weeks ago

Market Navigator: Hims & Hers Health up 250% in 2024

Dec 5, 2024, 9:30 AM EST - 6 weeks ago

Hims & Hers: The Show Must Go On

Dec 5, 2024, 8:30 AM EST - 6 weeks ago

Stock Picks From Seeking Alpha's November 2024 New Analysts

AMR BST CHGG CNXC CRGO CROX DT

Dec 5, 2024, 6:16 AM EST - 6 weeks ago

Hims & Hers Vs. Amazon: Why David Defeats Goliath

AMZN

Dec 4, 2024, 7:36 AM EST - 6 weeks ago

20 stocks likely to lag the S&P 500 over the next year — for this one reason

CELH CENX CNXC CRSR CXM FLG GEO

Dec 3, 2024, 12:58 PM EST - 6 weeks ago

Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category

Nov 29, 2024, 10:34 AM EST - 7 weeks ago

Hims & Hers: Driving Growth In Wellness

Nov 25, 2024, 6:44 PM EST - 7 weeks ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

IBB LLY MRNA NVO PFE

Nov 25, 2024, 6:22 PM EST - 7 weeks ago

Health care stocks jump on Trump's nominee for FDA head

IBB LFMD MRNA PFE

Nov 22, 2024, 8:55 AM EST - 2 months ago

What's Happening With HIMS Stock?

Nov 21, 2024, 4:56 PM EST - 2 months ago

The FDA Can't Decide Whether Zepbound Is in Shortage. It's Good News for Hims & Hers Stock.

Nov 21, 2024, 12:00 PM EST - 2 months ago

Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys

Nov 20, 2024, 1:15 PM EST - 2 months ago

Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead

Nov 18, 2024, 6:00 AM EST - 2 months ago

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Nov 16, 2024, 4:40 AM EST - 2 months ago

Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy

Nov 15, 2024, 12:37 PM EST - 2 months ago

Hims & Hers Health: The Amazon Curse Is Being Overstated

Nov 15, 2024, 8:10 AM EST - 2 months ago

Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs

AMZN

Nov 14, 2024, 2:40 PM EST - 2 months ago

Hims & Hers' stock tumbles on Amazon's latest disruptive foray into healthcare

AMZN

Nov 14, 2024, 11:18 AM EST - 2 months ago

Amazon's push into telehealth knocks shares of Hims & Hers

AMZN

Nov 14, 2024, 10:26 AM EST - 2 months ago

Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%

AMZN

Nov 13, 2024, 12:17 PM EST - 2 months ago

Telehealth firm Hims & Hers launches weight-loss drug shortage tracker

Nov 13, 2024, 9:15 AM EST - 2 months ago

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

Nov 12, 2024, 11:35 AM EST - 2 months ago

SHOP, CVNA, HIMS Highlight Strength & Diversity in Consumer Discretionary

CVNA SHOP

Nov 9, 2024, 10:00 AM EST - 2 months ago

Hims & Hers: Undeservedly Undervalued

Nov 8, 2024, 3:52 PM EST - 2 months ago

Hims & Hers: A High-Growth Gem On The Verge Of Big Upside

Nov 5, 2024, 4:31 PM EST - 2 months ago

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Nov 5, 2024, 2:27 PM EST - 2 months ago

Hims & Hers stock could dive soon despite strong results

Nov 5, 2024, 11:20 AM EST - 2 months ago

Hims & Hers Health CFO talks GLP-1s, earnings

Nov 5, 2024, 11:00 AM EST - 2 months ago

Hims & Hers Health: Another Blowout Quarter Ignored

Nov 5, 2024, 8:30 AM EST - 2 months ago

Hims & Hers Stock Jumps. A Generic Version of Novo Nordisk Diabetes Drug Is Close.

NVO

Nov 4, 2024, 10:30 PM EST - 2 months ago

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Nov 4, 2024, 8:58 PM EST - 2 months ago

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 6:28 PM EST - 2 months ago

Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating'

Nov 4, 2024, 6:10 PM EST - 2 months ago

Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025

NVO

Nov 4, 2024, 4:05 PM EST - 2 months ago

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 9:00 AM EDT - 2 months ago

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Oct 21, 2024, 9:00 AM EDT - 3 months ago

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Oct 17, 2024, 11:14 AM EDT - 3 months ago

HIMS: GLP-1 Is Just The Beginning

Oct 14, 2024, 4:40 PM EDT - 3 months ago

Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs

Oct 14, 2024, 4:05 PM EDT - 3 months ago

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Oct 11, 2024, 1:29 PM EDT - 3 months ago

Top 3 Stocks with Explosive Call Option Activity: What to Watch

GLD HOOD